Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia. - Wikidata - wikimedia - TriplyDB

Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia.

Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia.

http://www.wikidata.org/entity/Q34445822

about

Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis Is there a role for IGF-1 in the development of second primary cancers?Antagonists of retinoic acid receptors (RARs) are potent growth inhibitors of prostate carcinoma cells Does milk intake promote prostate cancer initiation or progression via effects on insulin-like growth factors (IGFs)? A systematic review and meta-analysis Resveratrol worsens survival in SCID mice with prostate cancer xenografts in a cell-line specific manner, through paradoxical effects on oncogenic pathways A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk Characterization of SV-40 Tag rats as a model to study prostate cancer.Growth hormone and prostate cancer: guilty by association?Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis.The association of diabetes mellitus and high-grade prostate cancer in a multiethnic biopsy series.Adult growth hormone deficiency in patients with fibromyalgia.Effect of low-intensity aerobic exercise on insulin-like growth factor-I and insulin-like growth factor-binding proteins in healthy men Acromegaly and cancer.Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study.Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes.Combination of dexamethasone and a somatostatin analogue in the treatment of advanced prostate cancer.Adiponectin: a link between obesity and cancer.Prognostic factors in prostate cancer.Lignans and human health.Acromegaly: re-thinking the cancer risk.Predictors of variation in serum IGF1 and IGFBP3 levels in healthy African American and white men.Effect of acute exercise on prostate cancer cell growth Prostate cancer: another aspect of the insulin-resistance syndrome?Androgen-induced PSA expression requires not only activation of AR but also endogenous IGF-I or IGF-I/PI3K/Akt signaling in human prostate cancer epithelial cells.Linking pre-diabetes with benign prostate hyperplasia. IGFBP-3: a conductor of benign prostate hyperplasia development orchestra?Role of breast cancer inhibitors on diabetes mellitus- an in silico approach.Emergence of metastatic hormone-refractory disease in prostate cancer after anti-androgen therapy.Global Igfbp1 deletion does not affect prostate cancer development in a c-Myc transgenic mouse model Tyrosine kinases expressed in vivo by human prostate cancer bone marrow metastases and loss of the type 1 insulin-like growth factor receptor Evaluation of insulin-like growth factor-I in postmenopausal women with breast cancer treated with raloxifene The association between paternal prostate cancer and type 2 diabetes Growth factor signalling in prostatic growth: significance in tumour development and therapeutic targeting.Drug Insight: lycopene in the prevention and treatment of prostate cancer.Intake of grains and dietary fiber and prostate cancer aggressiveness by race.Disruption of growth hormone signaling retards prostate carcinogenesis in the Probasin/TAg rat Examining the relationship between diet-induced acidosis and cancer.Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study Height-related risk factors for prostate cancer Cancers associated with acromegaly.Body weight and risk of soft-tissue sarcoma.

P2860

Q22252898-8D9E4682-39D8-4E10-9FC5-9755BCB1603F Q28069262-DEACD7A8-C0D8-47F7-AF79-DC5458937362 Q28345397-93791C04-FD22-4E73-B287-A9DC3FCF5332 Q30235013-40AAC89E-7408-4250-A7FD-CE9A3C50004F Q30538924-A69DD2BB-0238-4B03-9C1D-384FB26719B8 Q31049602-7508242E-CA2D-4FFF-89E0-26BA0B5B90C0 Q33403060-7C946D6C-730B-4F89-9A5C-C380F9281FFA Q33708557-5D636B5B-346E-43FD-BA86-D9D6D42AA648 Q33853206-D291A497-E200-4C9F-96AB-ABEF2D6EFA3A Q33896042-88D8EE68-2E4A-4D14-9B73-DE5B596E74D9 Q33960314-0D458E47-DC1A-42F2-9CEF-F64836999C49 Q34159376-CF4E3F9E-DF34-4A7C-91B9-CA880DE3763D Q34402037-C21F1B9D-EDC5-4F55-B98F-D50A1CE4E935 Q34473008-3D8B6F70-11FA-4DBD-803D-DD927AE3A495 Q34515989-9E4191F0-EA17-4634-A892-F9FA4C46F7CB Q34519166-EBD63C26-BFC7-46D6-8E48-DF429F9B8F31 Q34549919-6EEFA55B-0BCE-4790-8B86-DC7D213219AA Q34682069-E97B69AF-0189-41DF-BD3C-4DA427EF425A Q34702636-62B4A176-8624-494A-9282-E01235F6D6F6 Q34729995-33E5057A-E07C-48B1-9ED9-DFC3789C2CBC Q34788022-7C7A6721-28D8-4FFA-93DF-20C7BD5066E6 Q34825681-11185E19-2443-491F-895D-DC073D4ED02D Q35012809-B568A670-DBB2-4A6B-91BB-9E1E4EDB0CB5 Q35074494-25B6725B-97AD-4CE0-A1F1-6B2813CD8A47 Q35075205-14810EF2-6764-492E-8C3A-33EBCE97E70E Q35213224-680A2EAA-5DE0-437F-99B6-DB87359E4A09 Q35678545-08AC5BB8-424D-4F8D-8096-9120CABF955F Q35735568-18ED3A72-189C-4B4F-98E1-7008CE928EC5 Q35788293-80DC7F96-22FC-4EAF-9B99-8E281F0E2CC9 Q35933230-9811EA92-0816-477F-BDCF-A9A2CBB55A51 Q36094445-B062348E-6F99-4A7E-BC78-8B66933646E4 Q36390245-8C46544B-026E-49C7-993B-532E77E3AE1B Q36395073-D0CBA00C-10FB-4C10-88AB-2D872D969A65 Q36415432-480BCAEE-9341-4EC8-A1BA-3BF222A3A1A2 Q36509813-ACFB1790-3BCF-4413-B156-E6C0CF660E2D Q36608481-43436F22-5ABE-4853-A9F0-BB1772A8AAE2 Q36613659-438A3EE9-D764-4BF8-9966-76C5F2C98D92 Q36620814-04D0D003-0D80-40D8-B58F-2CD9CF9BB9C8 Q36626492-7A743675-A0E4-4759-BF52-97E4ECBF8230 Q36640912-B179059E-18E4-4956-8E26-E6B36A47642E

P2860

Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia.

http://www.wikidata.org/entity/Q34445822

description

1997 nî lūn-bûn

@nan

1997 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1997 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1997年の論文

@ja

1997年学术文章

@wuu

1997年学术文章

@zh-cn

1997年学术文章

@zh-hans

1997年学术文章

@zh-my

1997年学术文章

@zh-sg

1997年學術文章

@yue

name

Insulin-like growth factor 1 i ...... benign prostatic hyperplasia.

@ast

Insulin-like growth factor 1 i ...... benign prostatic hyperplasia.

@en

Insulin-like growth factor 1 i ...... benign prostatic hyperplasia.

@nl

type

label

Insulin-like growth factor 1 i ...... benign prostatic hyperplasia.

@ast

Insulin-like growth factor 1 i ...... benign prostatic hyperplasia.

@en

Insulin-like growth factor 1 i ...... benign prostatic hyperplasia.

@nl

prefLabel

Insulin-like growth factor 1 i ...... benign prostatic hyperplasia.

@ast

Insulin-like growth factor 1 i ...... benign prostatic hyperplasia.

@en

Insulin-like growth factor 1 i ...... benign prostatic hyperplasia.

@nl

P1433

Q34445822-22F94829-874D-4F56-A576-B521583B99D5

P1476

Q34445822-234D4A8A-12D2-4708-B6A4-50C9BC27F7DD

P2093

Q34445822-1DEEF48A-53E8-4BE6-B3D5-40865C9C9481

Q34445822-7098330A-0F45-4373-B025-DD71E7C4DA10

Q34445822-F52D1CF8-C92D-4456-AB8A-FFC226BC90DF

Q34445822-F7B8A798-51A3-441A-B07E-3DB4854058A9

P2860

Q34445822-1EE29472-5774-4B5E-9D77-68E8D51754D8

Q34445822-2167A0D8-317C-4E56-89BD-C5626195FF6F

Q34445822-22FB4162-E5F3-40AC-8F8B-DD062A0F5FB6

Q34445822-25AC9BC6-401B-43C3-88C4-587FF15E1781

Q34445822-585D3E79-A212-41CA-9F55-C21E6FFF5744

Q34445822-71198B4C-FEA3-40C3-ADFE-BE0F79124F83

Q34445822-88CD6A40-96EC-44F8-95A7-75BF2C58A761

Q34445822-94FF9F13-0907-4FB0-95BA-697E0F1246E5

Q34445822-C57441FC-B3D5-4DF8-982A-DFC58EE71E91

Q34445822-CDE647BF-1E01-4C45-8033-C97BFFA014A0

P2888

Q34445822-0EFF8F55-09D1-4933-B07A-396A0CCE0C13

P304

Q34445822-03F80B4F-BF92-4758-A27A-1F7A7C387F71

P31

Q34445822-E10CFF18-CD4B-4AC6-91D7-799B93B6EEA7

P356

Q34445822-20C3FCBD-E8D5-4ED1-A440-BE1CFD7530AB

P407

Q34445822-1815CE91-8105-465F-854B-A64CFCBAD1B6

P433

Q34445822-C0DEFA41-93C7-45BE-A3CF-89C6A900EF5C

P478

Q34445822-B00BD28B-E50F-4A11-91B6-E7B733F81B9F

P50

Q34445822-63EED0BB-C945-4ADD-8105-59F241794412

Q34445822-A9EF79F1-BDAC-46EA-BDCD-40297E5CB03A

P577

Q34445822-4663D355-9541-4BB1-9949-749B57977E4D

P5875

Q34445822-765EE1E7-2F93-407F-BC79-EA7DE8A4668C

P6179

Q34445822-B488A5A7-E880-4AFF-A648-AD55F1B54EBF

P698

Q34445822-A6B20176-CF13-437F-95E3-3A51A58544FA

P921

Q34445822-2C7024A6-AD66-4160-B2A1-A51BB7F4012F

P932

Q34445822-BC9B2F2D-DAFA-414F-A3AA-2F00340CF869

P356

P1433

British Journal of Cancer

P1476

Insulin-like growth factor 1 i ...... benign prostatic hyperplasia.

@en

P2093

A Tzonou

http://www.w3.org/2001/XMLSchema#string

C S Mantzoros

http://www.w3.org/2001/XMLSchema#string

L B Signorello

http://www.w3.org/2001/XMLSchema#string

M Stampfer

http://www.w3.org/2001/XMLSchema#string

P2860

Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins in primary cultures of prostate epithelial cells.

NIH conference. Insulin-like growth factors in health and disease.

Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo.

Clinical review 18: Are patients with acromegaly at increased risk for neoplasia?

The possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumors.

Inhibition of growth of prostatic cancer cell lines by peptide analogues of insulin-like growth factor 1.

Risk of endometrial and breast cancer in patients with diabetes mellitus.

Review of the role of androgenic hormones in the epidemiology of benign prostatic hyperplasia and prostate cancer.

Clinical review: 67: Approach to chemoprevention of prostate cancer.

Repression of the insulin receptor promoter by the tumor suppressor gene product p53: a possible mechanism for receptor overexpression in breast cancer.

P2888

P304

1115-1118

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.1997.520

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

76

http://www.w3.org/2001/XMLSchema#string

P50

Dimitrios Trichopoulos

Hans-Olov Adami

P577

1997-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13865021

http://www.w3.org/2001/XMLSchema#string

P6179

1053695852

http://www.w3.org/2001/XMLSchema#string

P698

9365156

http://www.w3.org/2001/XMLSchema#string

P921

P932

2228109

http://www.w3.org/2001/XMLSchema#string